Cart
sales@molnova.com
TMB
CAS No. 54827-17-7
TMB( BM blue | Sure Blue TMB )
Catalog No. M24534 CAS No. 54827-17-7
TMB is a chromogenic substrate. It used in staining procedures in immunohistochemistry and a visualizing reagent used in ELISA.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 31 | In Stock |
|
Biological Information
-
Product NameTMB
-
NoteResearch use only, not for human use.
-
Brief DescriptionTMB is a chromogenic substrate. It used in staining procedures in immunohistochemistry and a visualizing reagent used in ELISA.
-
DescriptionTMB is a chromogenic substrate. It used in staining procedures in immunohistochemistry and a visualizing reagent used in ELISA.
-
In Vitro——
-
In Vivo——
-
SynonymsBM blue | Sure Blue TMB
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number54827-17-7
-
Formula Weight240.34
-
Molecular FormulaC16H20N2
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (416.08 mM; Need ultrasonic)
-
SMILESNC1=C(C)C=C(C2=CC(C)=C(N)C(C)=C2)C=C1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
[Lys1015,1024]-Throm...
4N1K peptide is a biological active peptide. (4N1K-peptide (KRFYVVMWKK), which is derived from thrombospondins has anti-cancer activities in several cancers)
-
LDC7559
LDC7559 inhibits gasdermin D (GSDMD) by blocking neutrophil extracellular trap (NET) at late stage.
-
PAR-3 (1-6) (human)
PAR3 (1-6) is a synthetic peptide agonist of proteinase-activated receptor 1 (PAR1) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of human PAR3 and residues 39-44 of the full-length human sequence. PAR3 (1-6) activates p42/44 MAPK signaling in fibroblasts expressing PAR1, but not PAR3, an effect that can be blocked by the PAR1 antagonist RWJ 56110.
